Medacist Announces Commercial Release of RxAuditor Investigate – The First Offering of the Genesis Analytics Platform


CHESHIRE, CT, October 9, 2019 – David J. Brzozowski, Sr, President & CEO, today announced the commercial release of RxAuditor Investigate.

“I am proud to announce that Medacist Solutions Group commercially released RxAuditor Investigate on October 1, 2019.

As the innovative leader in drug diversion analytics for the healthcare industry, we do not rest on our laurels. The Medacist Development Team is always looking to improve the overall customer experience and will work diligently to advance the algorithmic processes to deliver the highest level of diversion intelligence in the industry to ensure accurate, comprehensive, and innovative drug diversion analytics for your organization.”

Please download the entire press release below.